Thomas Stankovich - 02 Nov 2021 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role
Chief Financial Officer
Signature
/s/ Thomas Stankovich
Issuer symbol
RSLS
Transactions as of
02 Nov 2021
Net transactions value
-$11,621
Form type
4
Filing time
16 Nov 2021, 15:14:25 UTC
Previous filing
12 Oct 2021
Next filing
18 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RSLS Common Stock, $0.001 par value per share Sale $11,621 -4,320 -1.2% $2.69 350,011 02 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) These shares were sold to cover taxes in connection with the vesting of restricted stock units.